- Raised $2.1M funding round, Jan 2026
- Raised $1.3M funding round, Aug 2025
- Raised $2.1M funding round, Nov 2024
About
HeraMED is a technology start-up company developing connected pregnancy monitoring solutions for home use. HeraMEDs hardware solutions and software applications are focused on fetal well-being and parental assurance. The companys HeraBEAT is a medically accurate and scientifically optimized smartphone-based fetal heartbeat monitor for home use. HeraBEAT allows expectant mothers to monitor the fetal heartbeat anytime, anywhere and enables the seamless sharing of fetal vital sign data with medical professionals. HeraBEAT integrates technology and professional accuracy with a simple and straightforward user interface and a distinctive design, resulting in a safe, reliable, and affordable solution. HeraBEAT is BSI certified with the CE mark for medical devices. It received 510(k) clearance from the FDA in November 2019. The companys HeraCARE is a digital platform enabling a new model of care for women throughout pregnancy. HeraMEDs future products include the EchoBEAT line of home-based pregnancy monitoring devices and ORION, an AI-powered pregnancy monitoring system. Developed in cooperation with the Mayo Clinic, Orion is trained to detect precursors that can indicate possible pregnancy complications before they become a problem.
Funding history · 12 rounds · $23.8M total
Q&A
- What is HeraMED's primary focus?
- HeraMED is a technology startup company that develops connected pregnancy monitoring solutions for in-home use, focusing on fetal well-being and parental assurance.
- What is HeraMED's flagship product for fetal monitoring?
- HeraMED's flagship product is HeraBEAT, a smartphone-based fetal heartbeat monitor designed for home use. It allows expectant mothers to monitor fetal heartbeats and share data with medical professionals.
- When did HeraMED receive FDA clearance for HeraBEAT?
- HeraBEAT received 510(k) clearance from the FDA in November 2019.
- What is HeraCARE?
- HeraCARE is a digital platform developed by HeraMED that enables a new model of care for women throughout their pregnancy.
- What are HeraMED's future product plans?
- HeraMED's future products include the EchoBEAT line of home-based pregnancy monitoring devices and ORION, an AI-powered pregnancy monitoring system developed in cooperation with the Mayo Clinic.
- What is the purpose of the ORION system?
- The ORION system, developed with the Mayo Clinic, is an AI-powered pregnancy monitoring system trained to detect precursors that may indicate possible pregnancy complications before they become a problem.
- What was HeraMED's most recent funding round?
- HeraMED's most recent funding round was in January 2026, raising $2,150,000.
- Which investor participated in HeraMED's July 2020 funding round?
- Mayo Clinic participated in HeraMED's funding round in July 2020.
Team · 2
Sectors & technology
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | hera-med.com |
|---|---|
| linkedin.com/company/5047695 | |
| facebook.com/herabeatil | |
| YouTube | youtube.com/channel/UCAlTYsc6t6y01nW1NsexhXQ |
Identifiers & details
| Founded | 2011-10 |
|---|---|
| Employees (exact) | 19 |
| Offices | Sydney |
| Market cap | $25.7M |
| Status reason | Public on ASX on Dec 2018; |
Radar intelligence
Web history (Wayback)
| Domain | hera-med.com |
|---|
Certificate / subdomain footprint
| Subdomains | 2 |
|---|